BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

668 related articles for article (PubMed ID: 23006238)

  • 1. Clozapine: balancing safety with superior antipsychotic efficacy.
    Meltzer HY
    Clin Schizophr Relat Psychoses; 2012 Oct; 6(3):134-44. PubMed ID: 23006238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does switching to another antipsychotic in patients with clozapine-associated granulocytopenia solve the problem? Case series of 18 patients.
    Coşar B; Taner ME; Eser HY; Altınöz AE; Tarhan R
    J Clin Psychopharmacol; 2011 Apr; 31(2):169-73. PubMed ID: 21346615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing treatment with clozapine.
    Conley RR
    J Clin Psychiatry; 1998; 59 Suppl 3():44-8. PubMed ID: 9541338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clozapine: the commitment to patient safety.
    Alphs LD; Anand R
    J Clin Psychiatry; 1999; 60 Suppl 12():39-42. PubMed ID: 10372610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clozapine-associated agranulocytosis: risk and aetiology.
    Krupp P; Barnes P
    Br J Psychiatry Suppl; 1992 May; (17):38-40. PubMed ID: 1418887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood dyscrasias in clozapine-treated patients in Italy.
    Lambertenghi Deliliers G
    Haematologica; 2000 Mar; 85(3):233-7. PubMed ID: 10702809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine treatment after agranulocytosis induced by classic neuroleptics.
    Bauer M; Mackert A
    J Clin Psychopharmacol; 1994 Feb; 14(1):71-3. PubMed ID: 7908676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond white blood cell monitoring: screening in the initial phase of clozapine therapy.
    Cohen D; Bogers JP; van Dijk D; Bakker B; Schulte PF
    J Clin Psychiatry; 2012 Oct; 73(10):1307-12. PubMed ID: 23140648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine for refractory schizophrenia: an open study of 14 patients treated up to 2 years.
    Mattes JA
    J Clin Psychiatry; 1989 Oct; 50(10):389-91. PubMed ID: 2571612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clozapine screening: white bloodcell counts no longer sufficient].
    Cohen D;
    Tijdschr Psychiatr; 2010; 52(11):785-90. PubMed ID: 21064021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clozapine use in geriatric patients- Challenges.
    Mukku SSR; Sivakumar PT; Varghese M
    Asian J Psychiatr; 2018 Mar; 33():63-67. PubMed ID: 29529421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clozapine].
    Inada K; Ishigooka J
    Nihon Rinsho; 2013 Apr; 71(4):678-83. PubMed ID: 23678599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clozapine's critical role in treatment resistant schizophrenia: ensuring both safety and use.
    Remington G; Lee J; Agid O; Takeuchi H; Foussias G; Hahn M; Fervaha G; Burton L; Powell V
    Expert Opin Drug Saf; 2016 Sep; 15(9):1193-203. PubMed ID: 27207070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maximizing clozapine therapy: managing side effects.
    Lieberman JA
    J Clin Psychiatry; 1998; 59 Suppl 3():38-43. PubMed ID: 9541337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agranulocytosis monitoring with Clozapine patients: to follow guidelines or to attempt therapeutic controversies?
    Chandrasekaran PK
    Singapore Med J; 2008 Feb; 49(2):96-9. PubMed ID: 18301833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis.
    Hägg S; Rosenius S; Spigset O
    Int Clin Psychopharmacol; 2003 May; 18(3):173-4. PubMed ID: 12702898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Risk minimization evolution of agranulocytosis caused by the administration of pharmaceutical products containing Clozapine in Argentina].
    Bergman M; Bignone I; Bisio A; Bologna V; Sabatini A
    Vertex; 2011; 22(96):94-7. PubMed ID: 21977603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the clozapine national registry system on incidence of deaths related to agranulocytosis.
    Honigfeld G
    Psychiatr Serv; 1996 Jan; 47(1):52-6. PubMed ID: 8925346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clozapine-induced agranulocytosis. Incidence and risk factors in the United States.
    Alvir JM; Lieberman JA; Safferman AZ; Schwimmer JL; Schaaf JA
    N Engl J Med; 1993 Jul; 329(3):162-7. PubMed ID: 8515788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controls on clozapine must be reviewed.
    Drew LR
    Aust N Z J Psychiatry; 2010 May; 44(5):490. PubMed ID: 20397797
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 34.